References Mashayekhi M, Beckman JA, Nian H, Garner EM, Mayfield D, Devin JK, et al
Therefore, a formulation of exenatide based on microsphere technology using fusion with poly(d,l-lactide- co -glycolic acid) was developed [17]
Drugmakers feared that using the GLP-1 medications with insulin might raise the chance of dangerously low blood sugar events, or hypoglycemia, and were unwilling to take the risk of studying them in people with type 1
Single-dose study in diet-induced obese (DIO) mice Male C57Bl/6 mice (Jackson Labs
This guide covers everything you need to know about adjusting your GLP-1 dose schedule if you, for any reason, miss your scheduled shot
[ FDA News Release, March 8, 2024